Statements of Operations
Ended March 31,
Research and development costs
General and administrative expenses
Depreciation and amortization
Total operating expenses
Nonoperating income (expense):
Warrant issuance and modification expense
Gain (loss) from change in fair value adjustment of warrant obligations
Total nonoperating income (expense)
Net loss attributable to common shareholders
Net loss per share - basic and diluted
Weighted average common shares outstanding - basic and diluted
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All